Company Presentation
SETTLEMENTS is a company incorporated under Belgian law on July 28th, 2008 and formerly named Assured. This name was changed in SETTLEMENTS SA on April 11th, 2011.The company is active in the acquisition and the management of US Life Settlements Portfolios.
A financial transaction in which the beneficiary of a redundant US life insurance policy, transfers, against the payment of a certain purchase price, such beneficiary clause to a third party generally for more than the cash value offered by the underwriting life insurance company. The purchaser becomes the new beneficiary of the policy at maturation and is responsible for all subsequent premium payments. If he fails to make such payments, the policy may lapse before it matures. The purchaser of a life settlement policy therefore takes the actuarial risk of the insured outliving his or her life expectancy, as was assessed by a medical underwriter at the time of purchase. Purchasers therefore determine the price they are willing to pay in function of the risk premium that is required to compensate such longevity risks
Settlements’ shares are listed in US dollars
The initial listing of SETTLEMENTS (ticker code: STTL) was realized through direct listing procedure further to the admission of 270.000 existing shares of the Company, among which 260.000 new shares placed with qualified investors via a private placement
Settlements SA aims to become one of the leader in the field of “life settlements market”. Currently Settlements has already identified the first Portfolio but not purchased yet.
Settlements benefits of the expertise of professional consultants specialized in its sector and it is audited by audit firms of international reputation.
To finance the acquisition of those Portfolios, the Company intends to issue bonds and to publicly offer them in Belgium. The Company intends also to list those bonds on the NYSE Alternext in Brussels and, if so, this may be the first bond listing on this market.
Investors returns on those bonds will be mainly non related to the financial market but will be based on the actuarial performance of the Portfolios.